Renal Cancer - Results from #4540

The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma March 28, 2018

Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update March 28, 2018

Prognostic significance of the dynamic changes of systemic inflammatory response in metastatic renal cell carcinoma March 27, 2018

Association of body mass index with mortality and postoperative survival in renal cell cancer patients, a meta-analysis March 27, 2018

Role of RPLND and Metastasectomy in the Management of Oligometastatic Renal Cell Carcinoma March 27, 2018

[Systemic immune checkpoint inhibition : A promising treatment for urological tumors?] March 26, 2018

Renal cell carcinoma: a review of biology and pathophysiology March 26, 2018

Processed Meat and Risk of Renal Cell and Bladder Cancers March 26, 2018

Radiotherapy and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors in Renal Cancer March 23, 2018

Synergy of Sex Differences in Visceral Fat Measured with CT and Tumor Metabolism Helps Predict Overall Survival in Patients with Renal Cell Carcinoma March 22, 2018

Efficacy of tivozanib treatment after sorafenib in patients with advanced renal cell carcinoma: crossover of a phase 3 study March 20, 2018

Ingested Nitrate, Disinfection By-products, and Kidney Cancer Risk in Older Women March 19, 2018

The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis March 19, 2018

Hereditary Kidney Cancer Syndromes and Surgical Management of the Small Renal Mass. March 19, 2018

Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials March 19, 2018

Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma March 19, 2018

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial March 19, 2018

Surgical Techniques in the Management of Small Renal Masses March 15, 2018

Comparative Effectiveness of Surgical Treatments for Small Renal Masses March 15, 2018

Active Surveillance in Small Renal Masses in the Elderly: A Literature Review March 14, 2018

Page 228 of 456